Pediatric Cancer: Clinical Trials

10 trials for Pediatric Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 3 unknown, 1 not yet recruiting, 1 recruiting. 10 Phase 3, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 310Completed 4, Unknown 3, Not yet recruiting 1, Recruiting 1, Terminated 1
Phase 24Completed 2, Unknown 2

Follow Pediatric Cancer: new trials by email Literature Review of Pediatric Cancer trials Research Report on Pediatric Cancer

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Olanzapine for Prevention of Vomiting in Children and Adolescents Receiving Highly Emetogenic Chemotherapy
Olanzapine Tablets, Placebo - Breakthrough Chemotherapy-Induced Vomiting (CIV) in Pediatric Patients, Pediatric Cancer
Phase 3Not yet recruitingShanghai Children's Medical Center1002025-07-012025-06-25
Pediatric Oncology Nutrition Intervention Trial
Oral Nutrition Supplement, Tube Feed, Cyproheptadine - Pediatric Cancer, Nutrition Related Cancer
Phase 2 / Phase 3CompletedCorey Hawes202024-01-312026-10-08
Continuous Infusion of First-Generation 5-HT3 Receptor Antagonists in Combination With Dexamethasone
Ondansetron, Dexamethasone - Pediatric Cancer
Phase 3CompletedImmune Oncology Research Institute282023-06-272026-06-08
Sequential PD-1/PD-L1 Inhibitor and LENvatinib in TLCT and Refractory Hepatoblastoma After Chemotherapy
PD-1 inhibitor - Transitional Cell Tumor, Hepatoblastoma
Phase 2 / Phase 3UnknownRenJi Hospital152022-04-102022-04-11
Comparing TIVA Using Propofol or Dexmedetomidine Versus Sevoflurane During Anaesthesia of Children Undergoing Bone-Marrow Aspiration
Sevoflurane, Propofol infusion for maintance, Dexmedetomidine - Invasive Cancer, Pediatric Cancer
Phase 2 / Phase 3CompletedAlexandria University602022-02-152022-12-05
Intranasal Versus Intravenous Drug in Painful Procedure for Outpatient Oncologic Participants
intranasal dexmedetomidine, intranasal fentanyl, intravenous ketamine (ketalar®) - Pediatric Cancer, Analgesia
Phase 3UnknownUniversity of Sao Paulo General Hospital602021-06-012021-04-01
Continuous Erector Spinae Block for Post Analgesia in Pediatric Patients
Bupivacaine Hydrochloride, Tramadol hydrochloride - Pediatric Cancer
Phase 3CompletedAssiut University602020-11-202023-02-03
the Efficacy and Safety of Sugammadex in Children 0-2 Years Old
Sugammadex - Anesthesia, Pediatric Cancer
Phase 2 / Phase 3UnknownFederal Research Institute of Pediatric Hematology, Oncology and Immunology622018-11-152018-11-02
A Prospective Clinical Cohort Study on Stratified Treatment of Rhabdomyosarcoma Based on Risk Factors.
VAC,VAC/VII,CAV/IE - Rhabdomyosarcoma, Pediatric Cancer
Phase 3RecruitingYizhuo Zhang3002017-01-302025-02-20
Early Stoppage Versus Continuation of Antimicrobial Therapy in Low Risk Pediatric Cancer Patients With Febrile Neutropenia, Before Recovery of Counts: -DALFEN Study
stoppage of antibiotics, amoxycillin/clavulanic acid, levofloxacin - Neutropenia, Febrile, Pediatric Cancer
Phase 3TerminatedAll India Institute of Medical Sciences1422017-01-012019-02-01

Narrower conditions

Neoplasms (10)  ·  Hepatoblastoma (2)  ·  Agnosia (1)  ·  Child Nutrition Disorders (1)  ·  Febrile Neutropenia (1)  ·  Liver Neoplasms (1)  ·  Muscular Atrophy (1)  ·  Pain, Procedural (1)  ·  Rhabdomyosarcoma (1)  ·  Vomiting (1)  ·  beta-Thalassemia (1)

Broader conditions

Neoplasms by Histologic Type (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Signs and Symptoms (3)  ·  Hematologic Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Neoplasms, Complex and Mixed (2)  ·  Nervous System Diseases (2)  ·  Neurologic Manifestations (2)  ·  Agranulocytosis (1)  ·  Anemia (1)  ·  Anemia, Hemolytic (1)  ·  Anemia, Hemolytic, Congenital (1)  ·  Atrophy (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Cytopenia (1)

Interventions

Olanzapine (2)  ·  Amoxicillin-Potassium Clavulanate Combination (1)  ·  Bupivacaine (1)  ·  Cyproheptadine (1)  ·  Dexamethasone (1)  ·  Dexmedetomidine (1)  ·  Enteral Nutrition (1)  ·  Immune Checkpoint Inhibitors (1)  ·  Ketamine (1)  ·  Levofloxacin (1)  ·  Ondansetron (1)  ·  Sevoflurane (1)  ·  Standard of Care (1)  ·  Sugammadex (1)  ·  Tramadol (1)

Sponsors

Alexandria University (1)  ·  All India Institute of Medical Sciences (1)  ·  Assiut University (1)  ·  Corey Hawes (1)  ·  Federal Research Institute of Pediatric Hematology, Oncology and Immunology (1)  ·  Immune Oncology Research Institute (1)  ·  RenJi Hospital (1)  ·  Shanghai Children's Medical Center (1)  ·  University of Sao Paulo General Hospital (1)  ·  Yizhuo Zhang (1)

Countries

China (3)  ·  Egypt (2)  ·  Armenia (1)  ·  Brazil (1)  ·  India (1)  ·  Russia (1)  ·  United States (1)

Top investigators

Anna Konstantinova, MD (1)  ·  Corey J Hawes, DCN, RD, CSO, CNSC, LD (1)  ·  Gevorg Tamamyan, MD, PhD, DSc (1)  ·  Hao Feng (1)  ·  Julieta Hoveyan, MD (1)  ·  Qiang Xia (1)  ·  Ruzanna Papyan, MD (1)  ·  Sameer Bakhshi, Professor (1)  ·  Samvel Bardakhchyan, MD, PhD (1)

Results publications

PMID 26768437, PMID 28325253, PMID 30246876, PMID 32568452, PMID 32931400, PMID 34400961, PMID 37539996

NIH funding

UL1TR001998 (1)